(0.18%) 5 109.09 points
(0.29%) 38 352 points
(0.23%) 15 965 points
(-1.38%) $82.69
(5.77%) $2.03
(0.16%) $2 351.00
(-0.07%) $27.52
(3.90%) $958.05
(-0.23%) $0.933
(-0.33%) $10.99
(-0.55%) $0.796
(1.67%) $93.41
3 days till quarter result
(bmo 2024-05-02)
Expected move: +/- 4.77%
Live Chart Being Loaded With Signals
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally...
Stats | |
---|---|
Dagens volum | 3.23M |
Gjennomsnittsvolum | 3.50M |
Markedsverdi | 73.37B |
EPS | $0 ( 2024-02-13 ) |
Neste inntjeningsdato | ( $1.350 ) 2024-05-02 |
Last Dividend | $0.375 ( 2023-10-31 ) |
Next Dividend | $0 ( N/A ) |
P/E | 31.64 |
ATR14 | $0.104 (0.06%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-04-18 | Lagano Roxanne | Sell | 923 | Common Stock |
2024-04-05 | Lagano Roxanne | Buy | 281 | Phantom Stock Unit |
2024-04-05 | Mamilli Wafaa | Buy | 411 | Phantom Stock Unit |
2024-04-05 | Joseph Wetteny | Buy | 581 | Phantom Stock Unit |
2024-04-05 | Driscoll Rimma | Buy | 16 | Phantom Stock Unit |
INSIDER POWER |
---|
-16.31 |
Last 100 transactions |
Buy: 87 523 | Sell: 122 271 |
Volum Korrelasjon
Zoetis Inc Korrelasjon
10 Mest positive korrelasjoner |
---|
10 Mest negative korrelasjoner |
---|
Visste du det?
Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).
Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.
Zoetis Inc Korrelasjon - Valuta/Råvare
Zoetis Inc Økonomi
Annual | 2023 |
Omsetning: | $8.54B |
Bruttogevinst: | $5.83B (68.28 %) |
EPS: | $5.08 |
FY | 2023 |
Omsetning: | $8.54B |
Bruttogevinst: | $5.83B (68.28 %) |
EPS: | $5.08 |
FY | 2022 |
Omsetning: | $8.08B |
Bruttogevinst: | $5.63B (69.63 %) |
EPS: | $4.51 |
FY | 2021 |
Omsetning: | $7.78B |
Bruttogevinst: | $5.47B (70.38 %) |
EPS: | $4.28 |
Financial Reports:
No articles found.
Zoetis Inc Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0.325 (N/A) |
$0.325 (N/A) |
$0.375 (N/A) |
$0.375 (N/A) |
$0.375 (N/A) |
$0.375 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | $0.0650 | 2013-04-29 |
Last Dividend | $0.375 | 2023-10-31 |
Next Dividend | $0 | N/A |
Payout Date | 2023-12-01 | |
Next Payout Date | N/A | |
# dividends | 43 | -- |
Total Paid Out | $7.38 | -- |
Avg. Dividend % Per Year | 0.50% | -- |
Score | 4.53 | -- |
Div. Sustainability Score | 10.00 | |
Div.Growth Potential Score | 5.76 | |
Div. Directional Score | 8.01 | -- |
Year | Amount | Yield |
---|---|---|
2013 | $0.195 | 0.63% |
2014 | $0.288 | 0.89% |
2015 | $0.332 | 0.77% |
2016 | $0.380 | 0.80% |
2017 | $0.420 | 0.78% |
2018 | $0.504 | 0.70% |
2019 | $0.656 | 0.78% |
2020 | $0.800 | 0.60% |
2021 | $1.000 | 0.61% |
2022 | $1.300 | 0.56% |
2023 | $1.500 | 1.02% |
2024 | $0 | 0.00% |
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
LOMA | Dividend Knight | 2023-06-30 | Quarterly | 2 | 5.23% | 8.53 |
ZTR | Dividend King | 2024-02-09 | Monthly | 37 | 8.35% | 8.50 |
ORC | Dividend Royal | 2023-11-29 | Monthly | 12 | 9.23% | 8.50 |
KIO | Dividend Royal | 2023-12-14 | Monthly | 12 | 7.05% | 8.50 |
NCZ | Dividend Royal | 2024-02-09 | Monthly | 22 | 7.79% | 8.50 |
SCM | Dividend King | 2023-12-15 | Monthly | 13 | 7.08% | 8.50 |
SJT | Dividend Royal | 2023-11-29 | Monthly | 39 | 12.52% | 8.50 |
GOF | Dividend Royal | 2023-11-14 | Monthly | 18 | 8.03% | 8.50 |
SRV | Dividend Royal | 2023-12-04 | Monthly | 18 | 7.53% | 8.50 |
VGI | Dividend Royal | 2024-02-09 | Monthly | 13 | 7.36% | 8.50 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.274 | 1.500 | 4.51 | 6.77 | [0 - 0.5] |
returnOnAssetsTTM | 0.164 | 1.200 | 4.53 | 5.44 | [0 - 0.3] |
returnOnEquityTTM | 0.488 | 1.500 | 5.68 | 8.53 | [0.1 - 1] |
payoutRatioTTM | 0.295 | -1.000 | 7.05 | -7.05 | [0 - 1] |
currentRatioTTM | 3.36 | 0.800 | 10.00 | 8.00 | [1 - 3] |
quickRatioTTM | 1.771 | 0.800 | 4.29 | 3.43 | [0.8 - 2.5] |
cashRatioTTM | 1.080 | 1.500 | 5.11 | 7.66 | [0.2 - 2] |
debtRatioTTM | 0.463 | -1.500 | 2.28 | -3.42 | [0 - 0.6] |
interestCoverageTTM | 12.94 | 1.000 | 6.32 | 6.32 | [3 - 30] |
operatingCashFlowPerShareTTM | 5.13 | 2.00 | 8.29 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 3.53 | 2.00 | 8.23 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 1.324 | -1.500 | 4.70 | -7.06 | [0 - 2.5] |
grossProfitMarginTTM | 0.696 | 1.000 | 1.735 | 1.735 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.374 | 1.000 | 4.52 | 4.52 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.356 | 1.000 | 9.13 | 9.13 | [0.2 - 2] |
assetTurnoverTTM | 0.598 | 0.800 | 9.35 | 7.48 | [0.5 - 2] |
Total Score | 10.25 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 31.02 | 1.000 | 6.97 | 0 | [1 - 100] |
returnOnEquityTTM | 0.488 | 2.50 | 7.23 | 8.53 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 3.53 | 2.00 | 8.82 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 1.019 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 5.13 | 2.00 | 8.29 | 10.00 | [0 - 30] |
payoutRatioTTM | 0.295 | 1.500 | 7.05 | -7.05 | [0 - 1] |
pegRatioTTM | 0 | 1.500 | -3.33 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.275 | 1.000 | 5.62 | 0 | [0.1 - 0.5] |
Total Score | 5.76 |
Zoetis Inc
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. The company also offers vaccines, which are biological preparations to prevent diseases of the respiratory, gastrointestinal, and reproductive tracts or induce a specific immune response; anti-infectives that prevent, kill, or slow the growth of bacteria, fungi, or protozoa; and parasiticides that prevent or eliminate external and internal parasites, which include fleas, ticks, and worms. It also provides other pharmaceutical products that comprise pain and sedation, antiemetic, reproductive, and oncology products; dermatology products for itch associated with allergic conditions and atopic dermatitis; and medicated feed additives, which offer medicines to livestock. In addition, the company provides portable blood and urine analysis testing, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, including nutritionals and agribusiness services, as well as products and services in areas, such as biodevices, genetics tests, and precision animal health. It markets its products to veterinarians, livestock producers, and retail outlets, as well as third-party veterinary distributors through its sales representatives, and technical and veterinary operations specialists. The company was founded in 1952 and is headquartered in Parsippany, New Jersey.
Om Live Signaler
Live Trading signaler pa denne siden er ment til å hjelpe deg i beslutningsprossessen for når du bør KJØPE eller SELGE NA. Signalene har opp mot 1-minutt forsinkelse; som med alle andre indikatorer og signaler, er det en viss sjanse for feil eller feilkalkuleringer.
Live signalene er kun veiledende, og getagraph.com tar ikke noen form for ansvar basert pa handlinger gjort på disse signalene som beskrevet i Terms of Use. Signalene er basert på en rekke indikatorer og påliteligheten vil variere sterke fra aksje til aksje.